Skip to content

Drug interactions

Efavirenz + Pasireotide

Severity: Moderate

Efavirenz and Pasireotide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs can prolong the QT interval, so combining them may raise the risk of torsades de pointes, especially with bradycardia, hypokalemia or hypomagnesemia. Pasireotide labeling advises caution with QT-prolonging drugs.

What this interaction means in plain words

Efavirenz and Pasireotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Efavirenz belongs to Anti Virals; Pasireotide belongs to Endocrine.

Evidence level: Moderate

Why it happens

Additive prolongation of cardiac repolarisation.

What to do

Obtain a baseline ECG and repeat it during therapy. Correct potassium and magnesium abnormalities.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Efavirenz and Pasireotide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Efavirenz with Pasireotide?

MediHelp rates the interaction as moderate. Efavirenz and Pasireotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs can prolong the QT interval, so combining them may raise the risk of torsades de pointes, especially with bradycardia, hypokalemia or hypomagnesemia. Pasireotide labeling advises caution with QT-prolonging drugs.

How serious is the interaction between Efavirenz and Pasireotide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and repeat it during therapy. Correct potassium and magnesium abnormalities.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Cobimetinib, Dienogest / estradiol valerate, Dihydroergotamine intranasal. The full list is on the Efavirenz page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in